FB-7011: A Novel, Long-Duration siRNA Dual-Targeting Both Complement Factor B (CFB) and Mannan-Binding Lectin Serine Protease 2 (MASP2) Exhibits Therapeutic Potential for Treatment of IgAN
用户jFEnCL9cudRQ
1个月前
81
10
已完结
1. 系统已在2026-03-07 11:42:35对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: https://journals.lww.com/10.1681/ASN.2025hjw1w0x0
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Michael Zhiyan Wang

